VTEU
Vaccine and Treatment Evaluation Units (VTEU)
- Obligated to date
- $231.2M
- Task orders
- 213
- Companies awarded
- 9
Vehicle overview
The Vaccine and Treatment Evaluation Units (VTEU) is an IDIQ managed by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct clinical trials evaluating vaccines, treatments, and diagnostics for infectious diseases. The vehicle supports the identification, design, and reporting of clinical studies targeting viral, bacterial, parasitic, and fungal pathogens, including priority biodefense and emerging infectious disease pathogens. It has a reported ceiling of $951,702,000 and serves as a critical resource for the NIAID's clinical research infrastructure.
The vehicle is restricted for use by NIAID and was awarded through full and open competition without set-asides. Its network of sites is integrated into the Infectious Diseases Clinical Research Consortium.
VTEU contract holders
| Contractor | Obligated | Task orders |
|---|---|---|
| UNIVERSITY OF MARYLAND, BALTIMORE | $51.9M | 30 |
| EMORY UNIVERSITY | $44.3M | 28 |
| DUKE UNIVERSITY | $30.4M | 27 |
| CHILDRENS HOSPITAL MEDICAL CENTER | $25.2M | 22 |
| VANDERBILT UNIVERSITY MEDICAL CENTER | $21.5M | 27 |
| BAYLOR COLLEGE OF MEDICINE | $19.5M | 20 |
| SAINT LOUIS UNIVERSITY | $17.0M | 26 |
| THE UNIVERSITY OF IOWA | $13.8M | 22 |
| KAISER FOUNDATION HEALTH PLAN OF WASHINGTON | $7.6M | 11 |
NAICS coverage
Frequently asked questions
- What is VTEU?
- The Vaccine and Treatment Evaluation Units (VTEU) is an IDIQ managed by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct clinical trials evaluating vaccines, treatments, and diagnostics for infectious diseases. The vehicle supports the identification, design, and reporting of clinical studies targeting viral, bacterial, parasitic, and fungal pathogens, including priority biodefense and emerging infectious disease pathogens. It has a reported ceiling of $951,702,000 and serves as a critical resource for the NIAID's clinical research infrastructure.
- Which agency manages VTEU?
- Vaccine and Treatment Evaluation Units (VTEU) is a IDIQ managed by National Institute of Allergy and Infectious Diseases (NIAID).
- What can agencies acquire through VTEU?
- The vehicle is restricted for use by NIAID and was awarded through full and open competition without set-asides. Its network of sites is integrated into the Infectious Diseases Clinical Research Consortium.
- How much has been obligated through VTEU?
- $231.2M has been obligated across 213 task orders.
- How many contractors hold VTEU?
- 9 contractors hold a position on VTEU.
- Is VTEU active?
- No, VTEU is not currently active — its status is expired.
Track the contracts behind VTEU
Sweetspot helps capture teams monitor awards, incumbents, recompetes, and agency demand across federal contract vehicles.
Schedule a Demo